PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Experimental Medicine, University of Tor Vergata, Rome, Italy. Electronic address: massimo.pieri@uniroma2.it.\', \'Tor Vergata University Hospital, Rome, Italy.\', \'Division of Cardiology, University of Rome Tor Vergata, Rome, Italy.\', \'Department of Experimental Medicine, University of Tor Vergata, Rome, Italy.\', \'Department of Experimental Medicine, University of Tor Vergata, Rome, Italy; Tor Vergata University Hospital, Rome, Italy.\', \'Department of Experimental Medicine, University of Tor Vergata, Rome, Italy; Tor Vergata University Hospital, Rome, Italy; IFCC Emerging Technologies Division, Milan, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1567-5769(21)00148-X10.1016/j.intimp.2021.107512
?:hasPublicationType
?:journal
  • International immunopharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33735714
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.051
?:rankingScore_hIndex
  • 94
is ?:relation_isRelatedTo_publication of
?:title
  • Serum Amyloid A Protein as a useful biomarker to predict COVID-19 patients severity and prognosis.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33735714>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33735714>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all